Images of Estrogen-Receptor-Positive Breast Tumors Produced by Estradiol Labeled With Iodine I 123 at 16α

Daniel E. Kenady, MD; Edward J. Pavlik, PhD; Katherine Nelson, PhD; John R. van Nagell Jr, MD; Holly Gallion, MD; Paul D. DePriest, MD; U. Yun Ryo, MD; Richard J. Baranczuk, PhD
Arch Surg. 1993;128(12):1373-1381. doi:10.1001/archsurg.1993.01420240081016.
Text Size: A A A
Published online

Objective:  To examine the suitability of estradiol labeled with iodine I 123 at 16α for imaging estrogenreceptor—positive breast carcinoma using imaging instrumentation that is widely available.

Design:  Single-photon emission computed tomographic imaging survey of 29 women with suspected primary or expected recurrent breast carcinoma.

Setting:  University-based referral center.

Participants:  Twenty-nine women undergoing diagnosis for primary or recurrent breast carcinoma. Selection was voluntary.

Main Outcome Measure:  Qualitative imaging study designed to provide tomographic data of radioligand retention and descriptive data of imaging results.

Results:  Single-photon emission computed tomographic imaging using 123I-estradiol at 16α was performed for patients with breast carcinoma. Independent readers, without knowledge of receptor status or proven disease, interpreted the films. Scintigraphic detection was most noteworthy in patients with chest wall tumors and inflammatory breast cancer. Agreement between readers was 98% for true-negative readings and 94% for true-positive readings, but only 60% for false-positive and false-negative film readings.

Conclusions:  Our results indicated that areas shown on imaging were also found to have estrogen-receptor activity and that radioligand accumulation can occur with low frequency in some surgically explored tissue. Radioligand imaging with 16α-123I-estradiol can locate estrogen-receptor—positive breast tumors, including some that may be difficult to detect using conventional diagnostic imaging.(Arch Surg. 1993;128:1373-1381)


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.